Even as BA.2 and "deltacron" set off feelings of panic or exhaustion, vaccinations and boosters continue to provide the best protection against severe disease, says Johns Hopkins immunologist Andy Pekosz
Findings differ from earlier reports of low antibody responses in children exposed to COVID-19 virus and suggest that even the youngest children may respond to vaccines if correct dose is determined
From the earliest days of COVID-19's detection and spread in January 2020, Johns Hopkins has played a critical role both globally and locally, as a trusted and indispensable source of reliable data, public health expertise, community support, and compassionate health care delivery
COVID-19 is inching toward endemic status in the U.S., but a clear seasonal pattern has yet to emerge. Meanwhile less than 66% of the total population has been vaccinated.
A pre-omicron study reviewed four vaccines, finding that they retain nearly all of their ability to prevent severe disease up to six months after full vaccination
In a small study of 14 infants and children, convalescent plasma from patients who recovered from COVID-19 infection provided expected antibody levels and raised no safety concerns